Hjem › Myelogen leukemi i kronisk fase › Oregon
Kliniske studier for Myelogen leukemi i kronisk fase i Oregon
4 studier for Myelogen leukemi i kronisk fase søker deltakere på steder i Oregon.
Byer i Oregon
Offisiell studietekst (engelsk)
Study of Olverembatinib (HQP1351) in Patients With CML-CP
- Ascentage Investigative Site #1139, Portland
RekruttererFase 3
Alder 18 og eldre · Alle kjønn · Oppdatert 15. sep. 2026 · NCT06423911A Real-world Chronic Myelogenous Leukemia (CML) Patient Disease Registry to Describe Patient Experience and Clinical Outcomes Among Patients With CML Receiving Approved First or Second Line Tyrosine Kinase Inhibitor (TKI) Therapy
- Oregon Oncology Specialists Salem, Salem
RekruttererObservasjonsstudie
Alder 18 til 100 · Alle kjønn · Oppdatert 20. jul. 2026 · NCT07091019A Phase 1a/1b Study of ELVN-001 for the Treatment Chronic Myeloid Leukemia
- Oregon Health & Science University-Knight Cardiovascular Institute, Portland
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 1. apr. 2026 · NCT05304377A Phase 1/2 Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of TERN-701 in Participants With Chronic Myeloid Leukemia (CARDINAL)
- Willamette Valley Cancer Institute and Research Center, Eugene
- Oregon Health & Science University, Portland
RekruttererFase 1/2
Alder 18 og eldre · Alle kjønn · Oppdatert 12. jan. 2026 · NCT06163430Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.